Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Once-daily fluticasone furoate is efficacious in patients with symptomatic asthma on low-dose inhaled corticosteroids.

Bleecker ER, Bateman ED, Busse WW, Woodcock A, Frith L, House KW, Jacques L, Davis AM, Haumann B, Lötvall J.

Ann Allergy Asthma Immunol. 2012 Nov;109(5):353-358.e4. doi: 10.1016/j.anai.2012.08.017.

PMID:
23062392
2.

Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.

Shepherd J, Rogers G, Anderson R, Main C, Thompson-Coon J, Hartwell D, Liu Z, Loveman E, Green C, Pitt M, Stein K, Harris P, Frampton GK, Smith M, Takeda A, Price A, Welch K, Somerville M.

Health Technol Assess. 2008 May;12(19):iii-iv, 1-360. Review.

3.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
4.

Inhaled mometasone furoate: a review of its use in adults and adolescents with persistent asthma.

Sharpe M, Jarvis B.

Drugs. 2001;61(9):1325-50. Review. Erratum in: Drugs 2001;61(11):1544.

PMID:
11511026
6.

The combination of fluticasone furoate and vilanterol trifenatate in the management of asthma: clinical trial evidence and experience.

Albertson TE, Richards JR, Zeki AA.

Ther Adv Respir Dis. 2016 Feb;10(1):43-56. doi: 10.1177/1753465815619136. Epub 2015 Dec 14. Review.

PMID:
26668137
7.

Spotlight on fluticasone furoate/vilanterol trifenatate for the once-daily treatment of asthma: design, development and place in therapy.

Albertson TE, Bullick SW, Schivo M, Sutter ME.

Drug Des Devel Ther. 2016 Dec 14;10:4047-4060. doi: 10.2147/DDDT.S113573. eCollection 2016. Review.

8.

Fluticasone furoate/vilanterol: a review of its use in patients with asthma.

Syed YY.

Drugs. 2015 Mar;75(4):407-18. doi: 10.1007/s40265-015-0354-5. Review.

PMID:
25648266
9.

Updates on the use of inhaled corticosteroids in asthma.

Stoloff SW, Kelly HW.

Curr Opin Allergy Clin Immunol. 2011 Aug;11(4):337-44. doi: 10.1097/ACI.0b013e328348a813. Review.

PMID:
21720220
10.

Inhaled fluticasone propionate and adrenal effects in adult asthma: systematic review and meta-analysis.

Masoli M, Weatherall M, Holt S, Shirtcliffe P, Beasley R.

Eur Respir J. 2006 Nov;28(5):960-7. Epub 2006 May 31. Review.

11.

Tiotropium for the treatment of adolescents with moderate to severe symptomatic asthma: a systematic review with meta-analysis.

Rodrigo GJ, Castro-Rodríguez JA.

Ann Allergy Asthma Immunol. 2015 Sep;115(3):211-6. doi: 10.1016/j.anai.2015.06.029. Epub 2015 Jul 29. Review.

PMID:
26231467
12.

Fluticasone furoate for the treatment of childhood asthma.

Phan H, Brown MA.

Expert Rev Respir Med. 2015 Aug;9(4):391-404. doi: 10.1586/17476348.2015.1068692. Epub 2015 Jul 16. Review.

PMID:
26184791
13.

The role of inhaled corticosteroids in management of asthma in infants and preschoolers.

Castro-Rodriguez JA, Pedersen S.

Curr Opin Pulm Med. 2013 Jan;19(1):54-9. doi: 10.1097/MCP.0b013e32835b1165. Review.

PMID:
23143197

Supplemental Content

Support Center